- Home
- DARE vs GIGM Comparison
DARE vs GIGM Comparison
Compare DARE & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DARE | GIGM |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 15.3M |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | DARE | GIGM |
|---|---|---|
| Price | $0.77 | $1.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 211.8K | 3.4K |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,807,885.00 | N/A |
| Revenue This Year | $163.80 | N/A |
| Revenue Next Year | $226.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $1.11 |
| 52 Week High | $3.78 | $1.72 |
Technical Indicators
Market Signals| Indicator | DARE | GIGM |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 47.55 |
| Support Level | $0.71 | $1.32 |
| Resistance Level | $0.88 | $1.50 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 37.02 | 53.85 |
Price Performance
Historical ComparisonAbout DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.